CN101757412A - Medicine composition for treating asthma - Google Patents

Medicine composition for treating asthma Download PDF

Info

Publication number
CN101757412A
CN101757412A CN200810158168A CN200810158168A CN101757412A CN 101757412 A CN101757412 A CN 101757412A CN 200810158168 A CN200810158168 A CN 200810158168A CN 200810158168 A CN200810158168 A CN 200810158168A CN 101757412 A CN101757412 A CN 101757412A
Authority
CN
China
Prior art keywords
grams
radix
asthma
treatment
bulbus fritillariae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810158168A
Other languages
Chinese (zh)
Inventor
葛沛呈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810158168A priority Critical patent/CN101757412A/en
Publication of CN101757412A publication Critical patent/CN101757412A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the field of traditional Chinese medicine prescription, in particular to a traditional Chinese medicine composition for treating asthma, which is mainly prepared from the following raw materials of: 10-30g of cacumen biotae, 11-16g of ginseng, 13-18g of kudzue vine root, 6-12g of cornus officinalis, 10-30g of moxa leaf, 4-10g of dandelion, 3-15g of Chinese magnoliavine fruit, 2-10g of rehmannia root, 3-6g of bulbus fritillariae cirrhosae, 5-10g of Dioscorea opposita, 25g of ephedra, 5-9g of cassia twig, 5-15g of radix ophiopogonis, 3-12g of dried tangerine peel, 2-15g of Rhizoma Pinellinae Praeparata, 4-20g of peony tree root bark, and 2-25g of honey. The invention has the advantages of good treatment effect, short treatment course, and less side effect.

Description

A kind of pharmaceutical composition for the treatment of asthma
Technical field:
The present invention relates to the Chinese medicine preparation field, especially a kind of pharmaceutical composition for the treatment of asthma.
Background technology:
Along with economical flourish in recent years, brought many negative influences also for people's life, for example environmental pollution etc. along with, thereby caused the rising of the sickness rate of human asthma, serious harm people healthy.For the various asthmas of human body, in prevention and treatment, still there is not ideal medicine both at home and abroad at present, though there are some medicines can manifest certain curative effect, but treatment time is long, and side effect is big, can't reach ideal effect, can only the respite symptom, be difficult to fundamentally disease thoroughly be cured.
Summary of the invention:
The invention provides a kind of pharmaceutical composition for the treatment of asthma, its therapeutic effect is good, and treatment time is short, and side effect is little, has solved problems of the prior art.
The present invention solves the problems of the technologies described above the technical scheme that is adopted to be: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 10~30 grams by the following raw materials in weight medicine; Radix Ginseng 11~16 grams; Radix Puerariae 13~18 grams; Mountain Zhu English 6~12 grams; Folium Artemisiae Argyi 10~30 grams; HUANGMIAO 4~10 grams, Fructus Schisandrae Chinensis 3~15 grams; Radix Rehmanniae 2~10 grams; Bulbus Fritillariae Cirrhosae 3~6 grams; Rhizomadioscoreae 5~10 grams; Herba Ephedrae 2~5 grams; Ramulus Cinnamomi 5~9 grams; Restrain Radix Ophiopogonis 5~15; Pericarpium Citri Reticulatae 3~12 grams; Rhizoma Pinelliae Preparata 2~15 grams; Cortex Moutan 4~20 grams; Mel 2~25 grams.
The concrete consumption of above-mentioned each crude drug is: Cacumen Platycladi 15 grams; Radix Ginseng 13 grams; Radix Puerariae 15 grams; Mountain Zhu English 8 grams; Folium Artemisiae Argyi 15 grams; HUANGMIAO 6 grams, Fructus Schisandrae Chinensis 10 grams; Radix Rehmanniae 7 grams; Bulbus Fritillariae Cirrhosae 4 grams; Rhizomadioscoreae 6 grams; Herba Ephedrae 3 grams; Ramulus Cinnamomi 6 grams; Restrain Radix Ophiopogonis 12; Pericarpium Citri Reticulatae 6 grams; Rhizoma Pinelliae Preparata 9 grams; Cortex Moutan 16 grams; Mel 18 grams.
The present invention has adopted numerous traditional treatment asthma Chinese herbal medicine compositions, and Cacumen Platycladi, Folium Artemisiae Argyi one a cold atmosphere is crossed slow profit each other and got, and is mutually proper clear, fill in puckery can rush down make under, Wen Xinneng is eliminating evil to go out key.Herba Houttuyniae and Ramulus Buxi Sinicae have the specially good effect of antiinflammatory, heat-clearing and toxic substances removing, expelling wind and removing dampness, and can improve blood circulation, the enhancing body immunity of human body.Mel is transferred to moisten the QI invigorating invigorating middle warmer, and it is capable to reach dirty peace internal organs.The curative effects such as bronchial asthma, asthmatic bronchitis, intractable cough of body being considered weak person and outbreak repeatedly are excellent.By the clinical trial certificate of 160 many cases asthma patients, this medicine is after treating three courses of treatment, and the overwhelming majority can recover normal, its cure rate reaches about 92%, and its effective percentage reaches more than 98%, and side effect is little, and expectorant, cough, breathe heavily, inflammation and General Symptoms improve, the getting rid of illness of asthmatic patient clothes.
The specific embodiment:
For clearly demonstrating the technical characterstic of this programme, below by the specific embodiment, the present invention will be described in detail.
Embodiment 1: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 15 grams by the following raw materials in weight medicine; Radix Ginseng 13 grams; Radix Puerariae 15 grams; Mountain Zhu English 8 grams; Folium Artemisiae Argyi 15 grams; HUANGMIAO 6 grams, Fructus Schisandrae Chinensis 10 grams; Radix Rehmanniae 7 grams; Bulbus Fritillariae Cirrhosae 4 grams; Rhizomadioscoreae 6 grams; Herba Ephedrae 3 grams; Ramulus Cinnamomi 6 grams; Restrain Radix Ophiopogonis 12; Pericarpium Citri Reticulatae 6 grams; Rhizoma Pinelliae Preparata 9 grams; Cortex Moutan 16 grams; Mel 18 grams.
Embodiment 2: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 13 by the following raw materials in weight medicine; Radix Ginseng 11; Radix Puerariae 10; Mountain Zhu English 8 grams; Folium Artemisiae Argyi 15 grams; HUANGMIAO 6 grams, Fructus Schisandrae Chinensis 10 grams; Radix Rehmanniae 7 grams; Bulbus Fritillariae Cirrhosae 4 grams; Rhizomadioscoreae 6 grams; Herba Ephedrae 3 grams; Ramulus Cinnamomi 6 grams; Restrain Radix Ophiopogonis 12; Pericarpium Citri Reticulatae 6 grams; Rhizoma Pinelliae Preparata 5; Cortex Moutan 14; Mel 18 grams.
Embodiment 3: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 12 by the following raw materials in weight medicine; Radix Ginseng 9; Radix Puerariae 8; Mountain Zhu English 7; Folium Artemisiae Argyi 13; HUANGMIAO 6 grams, Fructus Schisandrae Chinensis 10 grams; Radix Rehmanniae 7 grams; Bulbus Fritillariae Cirrhosae 4 grams; Rhizomadioscoreae 6 grams; Herba Ephedrae 3 grams; Ramulus Cinnamomi 6 grams; Restrain Radix Ophiopogonis 12; Pericarpium Citri Reticulatae 6 grams; Rhizoma Pinelliae Preparata 9 grams; Cortex Moutan 16 grams; Mel 18 grams.
Embodiment 4: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 10 Radix Ginsengs 8 Radix Puerariaes 8 by the following raw materials in weight medicine; Mountain Zhu English 7; Folium Artemisiae Argyi 13; HUANGMIAO 6 grams, Fructus Schisandrae Chinensis 10 grams; Radix Rehmanniae 7 grams; Bulbus Fritillariae Cirrhosae 4 grams; Rhizomadioscoreae 6 grams; Herba Ephedrae 3 grams; Ramulus Cinnamomi 6 grams; Restrain Radix Ophiopogonis 12; Pericarpium Citri Reticulatae 6 grams; Rhizoma Pinelliae Preparata 9 grams; Cortex Moutan 16 grams; Mel 18 grams.

Claims (2)

1. a pharmaceutical composition for the treatment of asthma is characterized in that: mainly made by the following raw materials in weight medicine: Cacumen Platycladi 10~30 grams; Radix Ginseng 11~16 grams; Radix Puerariae 13~18 grams; Mountain Zhu English 6~12 grams; Folium Artemisiae Argyi 10~30 grams; HUANGMIAO 4~10 grams, Fructus Schisandrae Chinensis 3~15 grams; Radix Rehmanniae 2~10 grams; Bulbus Fritillariae Cirrhosae 3~6 grams; Rhizomadioscoreae 5~10 grams; Herba Ephedrae 2~5 grams; Ramulus Cinnamomi 5~9 grams; Restrain Radix Ophiopogonis 5~15; Pericarpium Citri Reticulatae 3~12 grams; Rhizoma Pinelliae Preparata 2~15 grams; Cortex Moutan 4~20 grams; Mel 2~25 grams.
2. a kind of pharmaceutical composition for the treatment of asthma according to claim 1 is characterized in that: the concrete consumption of above-mentioned each crude drug is: Cacumen Platycladi 15 grams; Radix Ginseng 13 grams; Radix Puerariae 15 grams; Mountain Zhu English 8 grams; Folium Artemisiae Argyi 15 grams; HUANGMIAO 6 grams, Fructus Schisandrae Chinensis 10 grams; Radix Rehmanniae 7 grams; Bulbus Fritillariae Cirrhosae 4 grams; Rhizomadioscoreae 6 grams; Herba Ephedrae 3 grams; Ramulus Cinnamomi 6 grams; Restrain Radix Ophiopogonis 12; Pericarpium Citri Reticulatae 6 grams; Rhizoma Pinelliae Preparata 9 grams; Cortex Moutan 16 grams; Mel 18 grams.
CN200810158168A 2008-10-30 2008-10-30 Medicine composition for treating asthma Pending CN101757412A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810158168A CN101757412A (en) 2008-10-30 2008-10-30 Medicine composition for treating asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810158168A CN101757412A (en) 2008-10-30 2008-10-30 Medicine composition for treating asthma

Publications (1)

Publication Number Publication Date
CN101757412A true CN101757412A (en) 2010-06-30

Family

ID=42488896

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810158168A Pending CN101757412A (en) 2008-10-30 2008-10-30 Medicine composition for treating asthma

Country Status (1)

Country Link
CN (1) CN101757412A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103656422A (en) * 2013-11-20 2014-03-26 田博 Traditional Chinese medicine composition for treating asthmatic bronchitis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103656422A (en) * 2013-11-20 2014-03-26 田博 Traditional Chinese medicine composition for treating asthmatic bronchitis
CN103656422B (en) * 2013-11-20 2016-04-20 田博 A kind of Chinese medicine composition for the treatment of asthmatic bronchitis

Similar Documents

Publication Publication Date Title
CN100496586C (en) Medicinal liquor for treating hyperosteogency and koilorrhachic
CN103893639A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN103432503B (en) Traditional Chinese medicine composition
CN108030864A (en) A kind of strong medicine liquid for treating traumatic injury, burn and inflammation
CN1091609C (en) Tincture for treating rheumatoid arthritis and its preparing process
CN1390585A (en) Chinese medicine for detoxication purpose and its preparing process
CN100998656A (en) Medicated wine for tonifying bone and removing obstruction in channels
CN102526677A (en) Chinese medicine foot-massage composition for treating common cold due to wind-cold
CN1686085A (en) Bath liquid used for frostbite nursing and its preparation method
CN101912567B (en) Chinese medicinal prescription for treating chronic myocarditis
CN101138613A (en) Chinese traditional medicine for treating acute bronchitis of children
CN101450187A (en) Medicine composition for treating asthma
CN1657067A (en) Chinese medicine for treating psoriasis
CN100457168C (en) A traditional Chinese medicine for treating prostate diseases
CN103341063B (en) Chinese medicine composition for treating wind-heat cough
CN104491806A (en) External traditional Chinese medicine for treating allergic rhinitis
CN1879749A (en) Medicinal heath wine
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN103301411A (en) Traditional Chinese medicine wine for treating soft tissue injury and preparation method thereof
CN103656130A (en) Traditional Chinese medicine composition for treating constipation
CN101757412A (en) Medicine composition for treating asthma
CN103099879B (en) Traditional Chinese medicine (TCM) preparation for treating fifth-watch diarrhea
CN102228559B (en) Externally applied ointment for treating children eczema
CN101143199A (en) Traditional Chinese medicine for treating chronic bronchitis
CN101249212A (en) Externally used drug for curing epidemic parotitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100630